Indomethacin Eyedrops Compared With Ketorolac Eyedrops for Ocular Inflammation Following Cataract Surgery
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-20
- Last Posted Date
- 2012-08-13
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 120
- Registration Number
- NCT00904904
- Locations
- 🇩🇪
Bausch & Lomb, Berlin, Germany
Evaluation of BOL-303242-X Versus Vehicle for the Treatment of Inflammation Following Cataract Surgery
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-20
- Last Posted Date
- 2020-09-22
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 415
- Registration Number
- NCT00905450
- Locations
- 🇺🇸
Bausch & Lomb, Rochester, New York, United States
One-Day Dispensing Clinical Evaluation of SofLens Daily Disposable Lenses Compared to a Marketed 1 Day Contact Lens
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-15
- Last Posted Date
- 2015-03-02
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 28
- Registration Number
- NCT00902850
- Locations
- 🇺🇸
Bausch & Lomb Research Clinic, Rochester, New York, United States
Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-03-02
- Last Posted Date
- 2013-01-25
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 299
- Registration Number
- NCT00853970
- Locations
- 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States
Study of T-PRED(TM) Compared to Pred Forte(R) II
- First Posted Date
- 2009-03-02
- Last Posted Date
- 2020-10-20
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 172
- Registration Number
- NCT00854061
- Locations
- 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States
Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-06
- Last Posted Date
- 2011-12-09
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 125
- Registration Number
- NCT00838045
- Locations
- 🇩🇪
Klinikum der J.W. Goethe-Universität, Frankfurt, Germany
Safety and Effectiveness of the Akreos Toric Intraocular Lens.
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-01-21
- Last Posted Date
- 2013-03-25
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 198
- Registration Number
- NCT00825513
- Locations
- 🇸🇪
Dept. of Clinical Sciences/ Ophthalmology Umea University Hospital, Umea, Sweden
Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-01-16
- Last Posted Date
- 2011-12-13
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 105
- Registration Number
- NCT00824070
- Locations
- 🇺🇸
Ophthalmic Consultants of Long Island, Rockville Center, New York, United States
Evaluation of the Safety and Effectiveness of the Akreos MI Five-0 Intraocular Lens.
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2014-01-17
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 10
- Registration Number
- NCT00804726
- Locations
- 🇩🇪
Augenzentrum Maus Wolfsstr 16, Koln, Germany
Clinical Evaluation of a New Aspheric Intraocular Lens.
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-06
- Last Posted Date
- 2011-12-12
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 75
- Registration Number
- NCT00786565
© Copyright 2024. All Rights Reserved by MedPath